1.
Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.
J Biol Regul Homeost Agents
; 34(3): 757-766, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32462858
RESUMO
The aim of the multicentre study promoted by Nuova FIO is to evaluate the beneficial effects of the systemic Oxygen-Ozone (O2O3) therapy in patients suffering from SARS COV-2 disease in the early phases of the disease, before worsening, up to the need of tracheal intubation. The study is based on the rationale on that the systemic oxygen-ozone treatment could be effective, positively influencing the disease evolution and/or being able to mitigate the onset of the cytokine storm syndrome at least partially.